Abstract
Cardiogenic shock developed in a 72-year-old Japanese woman during combination therapy with verapamil and atenolol for recurrent supraventricular arrhythmia. She had coronary atherosclerosis, liver cirrhosis and bradycardia-tachycardia syndrome. Despite of the high-dose catecholamines and counterpulsation, she progressively deteriorated. Bolus administration of intravenous calcium chloride (CaCl2) immediately resolved her hemodynamic collapse.
MeSH terms
-
Adrenergic beta-Antagonists / administration & dosage
-
Adrenergic beta-Antagonists / adverse effects*
-
Aged
-
Atenolol / administration & dosage
-
Atenolol / adverse effects*
-
Atrial Fibrillation / drug therapy*
-
Atrial Fibrillation / etiology
-
Bradycardia / complications
-
Bradycardia / therapy
-
Calcium Channel Blockers / administration & dosage
-
Calcium Channel Blockers / adverse effects*
-
Calcium Channels, L-Type / drug effects
-
Calcium Channels, L-Type / physiology
-
Calcium Chloride / administration & dosage
-
Calcium Chloride / therapeutic use*
-
Combined Modality Therapy
-
Counterpulsation
-
Drug Interactions
-
Drug Therapy, Combination
-
Female
-
Humans
-
Hypertension / complications
-
Hypertension / diet therapy
-
Hypertrophy, Left Ventricular / complications
-
Injections, Intravenous
-
Liver Cirrhosis / complications
-
Pacemaker, Artificial
-
Shock, Cardiogenic / chemically induced*
-
Shock, Cardiogenic / drug therapy
-
Shock, Cardiogenic / therapy
-
Tachycardia, Supraventricular / drug therapy*
-
Tachycardia, Supraventricular / etiology
-
Tachycardia, Supraventricular / therapy
-
Vasodilator Agents / administration & dosage
-
Vasodilator Agents / adverse effects*
-
Verapamil / administration & dosage
-
Verapamil / adverse effects*
Substances
-
Adrenergic beta-Antagonists
-
Calcium Channel Blockers
-
Calcium Channels, L-Type
-
Vasodilator Agents
-
Atenolol
-
Verapamil
-
Calcium Chloride